830 | A PHASE 1 STUDY EVALUATING SAFETY, PHARMACOKINETICS, AND EFFICACY OF ABBV‐291, A CD79B‐TARGETING ADC IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: D. Maruyama, E. Gomez, M. Jalaluddin, K. Izeradjene, E. Greenberg, C. Ramathal, M. Ku
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!